Improvement of serum oxidation by pravastatin might be one of the mechanisms by which endothelial function in dilated coronary artery segments is ameliorated
- 1 August 2003
- journal article
- clinical trial
- Published by Elsevier in Atherosclerosis
- Vol. 169 (2) , 309-315
- https://doi.org/10.1016/s0021-9150(03)00197-7
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Pravastatin and endothelium dependent vasomotion after coronary angioplasty: the PREFACE trialHeart, 2001
- Long-Term Follow-Up of Patients With Mild Coronary Artery Disease and Endothelial DysfunctionCirculation, 2000
- Endothelial Dysfunction: Does It Matter? Is It Reversible?Journal of the American College of Cardiology, 1997
- Whole plasma oxidation assay as a measure of lipoprotein oxidizabilityBioFactors, 1997
- Copper-Induced Lipid Oxidation in Unfractionated Plasma: The Lag Preceding Oxidation as a Measure of Oxidation-ResistanceBiochemical and Biophysical Research Communications, 1995
- Pathogenesis of atherosclerosisThe American Journal of Cardiology, 1995
- Effects of Lipid Lowering by Pravastatin on Progression and Regression of Coronary Artery Disease in Symptomatic Men With Normal to Moderately Elevated Serum Cholesterol LevelsCirculation, 1995
- Continuous Monitoring ofin VztroOxidation of Human Low Density LipoproteinFree Radical Research Communications, 1989
- Effect of gender, age, and lipid status on low density lipoprotein subfraction distribution. Results from the Framingham Offspring Study.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1987
- Paradoxical Vasoconstriction Induced by Acetylcholine in Atherosclerotic Coronary ArteriesNew England Journal of Medicine, 1986